|Molecular Biology: MCB|
|This page has been transwikied to Wiktionary. |
The article has content that is useful at Wiktionary. Therefore the article can be found at either here or here (logs 1 logs 2.)
Note: This means that the article has been copied to the Wiktionary Transwiki namespace for evaluation and formatting. It does not mean that the article is in the Wiktionary main namespace, or that it has been removed from Wikipedia's. Furthermore, the Wiktionarians might delete the article from Wiktionary if they do not find it to be appropriate for the Wiktionary.
Removing this tag will usually trigger CopyToWiktionaryBot to re-transwiki the entry. This article should have been removed from Category:Copy to Wiktionary and should not be re-added there.
modes of action 2 & 3
Modes of action 2 & 3 are unclear: What is exactly inhibited wrt RNA? Is RNA transcription inhibited (likely since there is this big molecule in the way attached to the DNA) or is transcription inhibited?
Is point 3 a result of 1 & 2 or is there another mechanism?
MOAs 2 & 3 are vague and seem to be a direct result of 1. From my lecture notes here it seems that they work via inhibiting topoisomerase II. This also seems to be supported by what's on the anthracycline and doxorubicin pages. I have edited the page to reflect this. Serrin 08:32, 4 August 2006 (UTC)
Suggest Move to Antineoplastic agent.
- I rather suggest that this page should be moved to Cancer chemotherapy, after moving Chemotherapy to that one, as discussed at Talk:Chemotherapy: Move Chemotherapy to Cancer chemotherapy. Mikael Häggström (talk) 05:38, 17 May 2011 (UTC)
Discussion is found at Talk:Chemotherapy#Merge_Antineoplastic_into_Chemotherapy. Mikael Häggström (talk) 13:10, 18 May 2011 (UTC)